Notes on the epidemiology of multiple sclerosis. 1995

C M Poser
Department of Neurology, Harvard Medical School and Beth Israel Hospital, Boston, MA 02215, USA.

The single most important feature that determines the reliability of epidemiologic studies of multiple sclerosis (MS) is the use of well-defined, generally recognized diagnostic criteria. The long-accepted direct relationship between prevalence rates (PR) and latitude is no longer valid and has been replaced by the realization that genetic factors play an important role in the acquisition of the disease. The nature of environmental factors, which may be of more importance in influencing the clinical manifestations of the disease, remains obscure. Most potential risk factors that have been studied lack biologic plausibility. Biostatistical interpretation of epidemiologic data can only indicate possible causal relationships but cannot conclusively rule out their existence. Differences in PR among different ethnic groups in similar locations suggest that, in addition to genetic factors, there may be enhancing and/or protective influences which are probably environmental in nature. Migration studies have been interpreted as suggesting that MS is acquired before puberty and that age at migration is important in determining the risk of having clinical disease. Epidemics by age of onset vanish when recalculated on the basis of age of acquisition, and probably mean that more early and mild cases are being diagnosed. A new definition of PR is proposed, ie, onset-adjusted PR, which includes patients who had symptoms at the time of the survey, but had not yet been diagnosed as MS. However, individuals who had symptoms at the time of migration to a study area must not be included in PR.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D004641 Emigration and Immigration The process of leaving one's country to establish residence in a foreign country. Immigration,Labor Migration,Border Crossing,Chain Migration,Emigration,In-Migration,International Migration,Out-Migration,Return Migration,Settlement and Resettlement,Temporary Migration,Turnaround Migration,Border Crossings,Chain Migrations,Crossing, Border,Crossings, Border,Emigrations,Immigration and Emigration,Immigrations,In Migration,In-Migrations,International Migrations,Labor Migrations,Migration, Chain,Migration, International,Migration, Labor,Migration, Return,Migration, Temporary,Migration, Turnaround,Migrations, Chain,Migrations, International,Migrations, Labor,Migrations, Return,Migrations, Temporary,Migrations, Turnaround,Out Migration,Out-Migrations,Resettlement and Settlement,Return Migrations,Temporary Migrations,Turnaround Migrations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015994 Incidence The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases in the population at a given time. Attack Rate,Cumulative Incidence,Incidence Proportion,Incidence Rate,Person-time Rate,Secondary Attack Rate,Attack Rate, Secondary,Attack Rates,Cumulative Incidences,Incidence Proportions,Incidence Rates,Incidence, Cumulative,Incidences,Person time Rate,Person-time Rates,Proportion, Incidence,Rate, Attack,Rate, Incidence,Rate, Person-time,Rate, Secondary Attack,Secondary Attack Rates
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences

Related Publications

C M Poser
February 2014, International journal of molecular sciences,
C M Poser
May 2020, Brain and nerve = Shinkei kenkyu no shinpo,
C M Poser
September 1978, Neurology,
C M Poser
December 1992, Italian journal of neurological sciences,
C M Poser
July 1989, Mayo Clinic proceedings,
C M Poser
January 1984, Annals of neurology,
C M Poser
October 1969, Harefuah,
C M Poser
December 2007, Journal of neurology,
C M Poser
September 1997, Mayo Clinic proceedings,
C M Poser
January 1997, Acta neurologica Scandinavica. Supplementum,
Copied contents to your clipboard!